Comparison of Expression of Carcinogenesis-related Molecular Markers in the Patients With Colon Cancer and Polyp
NCT ID: NCT05638542
Last Updated: 2023-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
582 participants
OBSERVATIONAL
2015-03-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinicopathological Characteristics of Colon Cancer in Young Age
NCT05365412
Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer
NCT06114420
Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer
NCT05444491
Molecular Study and Precision Medicine for Colorectal Cancer
NCT05883683
Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer
NCT04287400
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Patients who are not diagnosed with colorectal adenoma or colorectal cancer
No interventions assigned to this group
Colorectal adenoma group
Patients who are diagnosed with colorectal adenoma
No interventions assigned to this group
Colorectal cancer group
Patients who are diagnosed with colorectal cancer
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Colorectal adenoma group: Patients with colorectal adenomas greater than or equal to 10 mm in diameter according to the endoscopic presentation as well as histological validation of colorectal adenoma.
* Colorectal cancer group: Patients whose biopsy specimen is histologically confirmed as colorectal adenocarcinoma
Exclusion Criteria
* Previous history of colorectal neoplasms
* Patients with high bleeding risk or patients who must maintain anti-coagulant or anti-platelet agents
* Denial to participate in this study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nayoung Kim
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nayoung Kim, M.D., Ph.D
Role: STUDY_CHAIR
Seoul National University Bundang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Choi J, Kim N, Nam RH, Kim JW, Song CH, Na HY, Kang GH. Influence of location-dependent sex difference on PD-L1, MMR/MSI, and EGFR in colorectal carcinogenesis. PLoS One. 2023 Feb 21;18(2):e0282017. doi: 10.1371/journal.pone.0282017. eCollection 2023.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-1305-203-009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.